UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 180

Sortiert nach

Phase II trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid

Thyroid (New York, N.Y.), 2013-05, Vol.23 (5), p.600

2013

Volltextzugriff (PDF)

Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors

JNCI : Journal of the National Cancer Institute, 2010-05, Vol.102 (9), p.596-604

2010

Volltextzugriff (PDF)

Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities

JNCI : Journal of the National Cancer Institute, 2014-09, Vol.106 (9), p.1

2014

Volltextzugriff (PDF)

Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients

Blood, 2013-11, Vol.122 (19), p.3251-3262

2013

Volltextzugriff (PDF)

Anaplastic Thyroid Cancer: A Review of Epidemiology, Pathogenesis, and Treatment

Journal of Oncology, 2011-01, Vol.2011, p.542358-13

2011

Volltextzugriff (PDF)

Combretastatin A4 phosphate: a novel vascular disrupting agent

Future oncology (London, England), 2010-08, Vol.6 (8), p.1219-1228

2010

Volltextzugriff (PDF)

Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors

The American heart journal, 2012-02, Vol.163 (2), p.156-163

2012

Volltextzugriff (PDF)

Targeting the secreted RGDKGE collagen fragment reduces PD‑L1 by a proteasome‑dependent mechanism and inhibits tumor growth

Oncology reports, 2023-02, Vol.49 (2), p.1, Article 44

2023

Volltextzugriff (PDF)

Definitive Upfront Stereotactic Ablative Radiotherapy Combined with Image-Guided, Intensity Modulated Radiotherapy (IG-IMRT) or IG-IMRT Alone for Locally Advanced Non-Small Cell Lung Cancer

PloS one, 2016-09, Vol.11 (9), p.e0162453

2016

Volltextzugriff (PDF)

Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma

Thyroid (New York, N.Y.), 2014-02, Vol.24 (2), p.232

2014

Volltextzugriff (PDF)

Outcomes of Chemoradiotherapy With 5-Fluorouracil and Mitomycin C for Anal Cancer in Immunocompetent Versus Immunodeficient Patients

International journal of radiation oncology, biology, physics, 2009-09, Vol.75 (1), p.143-149

2009

Volltextzugriff (PDF)

Disability-Adjusted Life-Years Due to Stroke in Kenya

Neuroepidemiology, 2019-08, Vol.53 (1-2), p.48-54

2019

Volltextzugriff (PDF)

Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma

Blood, 2010-04, Vol.115 (15), p.3008-3016

2010

Volltextzugriff (PDF)

Combining clinical, pathological, and demographic factors refines prognosis of lung cancer: a population-based study

PloS one, 2011-02, Vol.6 (2), p.e17493-e17493

2011

Volltextzugriff (PDF)

Factors influencing survival among Kenyan children diagnosed with endemic Burkitt lymphoma between 2003 and 2011: A historical cohort study

International journal of cancer, 2016-09, Vol.139 (6), p.1231-1240

2016

Volltextzugriff (PDF)

Hypertension, proteinuria, and antagonism of vascular endothelial growth factor signaling: clinical toxicity, therapeutic target, or novel biomarker?

Journal of clinical oncology, 2007-07, Vol.25 (21), p.2993-2995

2007

Volltextzugriff (PDF)

Phase I Pharmacokinetic and Pharmacodynamic Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an Inhibitor of Heat-Shock Protein 90, in Patients With Advanced Solid Tumors

Journal of clinical oncology, 2010-03, Vol.28 (9), p.1520-1526

2010

Volltextzugriff (PDF)

A Vasculature-Targeting Regimen of Preoperative Docetaxel with or without Bevacizumab for Locally Advanced Breast Cancer: Impact on Angiogenic Biomarkers

Clinical cancer research, 2009-05, Vol.15 (10), p.3583-3590

2009

Volltextzugriff (PDF)

Sibling Donor and Recipient Immune Modulation With Atorvastatin for the Prophylaxis of Acute Graft-Versus-Host Disease

Journal of clinical oncology, 2013-12, Vol.31 (35), p.4416-4423

2013

Volltextzugriff (PDF)

Confirmation of Gene Expression–Based Prediction of Survival in Non–Small Cell Lung Cancer

Clinical cancer research, 2008-12, Vol.14 (24), p.8213-8220

2008

Volltextzugriff (PDF)

A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome

Thyroid (New York, N.Y.), 2009-03, Vol.19 (3), p.233

2009

Volltextzugriff (PDF)

Drug Insight: vascular disrupting agents and angiogenesis-novel approaches for drug delivery

Nature clinical practice. Oncology, 2006-12, Vol.3 (12), p.682-692

2006

Volltextzugriff (PDF)

A Phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin A-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer

Cancer research (Chicago, Ill.), 2002-06, Vol.62 (12), p.3408-3416

2002

Volltextzugriff (PDF)

MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling

Oncotarget, 2016-07, Vol.7 (28), p.43960-43973

2016

Volltextzugriff (PDF)

Ocular surface squamous neoplasia in patients with HIV infection in sub-Saharan Africa

Current opinion in oncology, 2010-09, Vol.22 (5), p.437-442

2010

Volltextzugriff (PDF)

1 – 25 von 180

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(165)
Mit Volltextzugriff
(159)

Publikationsform

Artikel
(180)

Sprache

Englisch
(180)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Science & Technology
(130)
Humans
(127)
Life Sciences & Biomedicine
(126)
Oncology
(88)
Female
(85)
Middle Aged
(73)
Male
(72)
Adult
(67)
Biological And Medical Sciences
(61)
Medical Sciences
(61)
Aged
(56)
Pharmacology. Drug Treatments
(43)
Antineoplastic Agents
(40)
Chemotherapy
(35)
Neoplasms - Drug Therapy
(35)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(29)
Tumors
(27)
Treatment Outcome
(21)
Antineoplastic Agents - Adverse Effects
(19)
Cancer
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid

Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors

Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities

Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients

Anaplastic Thyroid Cancer: A Review of Epidemiology, Pathogenesis, and Treatment

Combretastatin A4 phosphate: a novel vascular disrupting agent

Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors

Targeting the secreted RGDKGE collagen fragment reduces PD‑L1 by a proteasome‑dependent mechanism and inhibits tumor growth

Definitive Upfront Stereotactic Ablative Radiotherapy Combined with Image-Guided, Intensity Modulated Radiotherapy (IG-IMRT) or IG-IMRT Alone for Locally Advanced Non-Small Cell Lung Cancer

Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma

Outcomes of Chemoradiotherapy With 5-Fluorouracil and Mitomycin C for Anal Cancer in Immunocompetent Versus Immunodeficient Patients

Disability-Adjusted Life-Years Due to Stroke in Kenya

Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma

Combining clinical, pathological, and demographic factors refines prognosis of lung cancer: a population-based study

Factors influencing survival among Kenyan children diagnosed with endemic Burkitt lymphoma between 2003 and 2011: A historical cohort study

Hypertension, proteinuria, and antagonism of vascular endothelial growth factor signaling: clinical toxicity, therapeutic target, or novel biomarker?

Phase I Pharmacokinetic and Pharmacodynamic Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an Inhibitor of Heat-Shock Protein 90, in Patients With Advanced Solid Tumors

A Vasculature-Targeting Regimen of Preoperative Docetaxel with or without Bevacizumab for Locally Advanced Breast Cancer: Impact on Angiogenic Biomarkers

Sibling Donor and Recipient Immune Modulation With Atorvastatin for the Prophylaxis of Acute Graft-Versus-Host Disease

Confirmation of Gene Expression–Based Prediction of Survival in Non–Small Cell Lung Cancer

A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome

Drug Insight: vascular disrupting agents and angiogenesis-novel approaches for drug delivery

A Phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin A-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer

MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling

Ocular surface squamous neoplasia in patients with HIV infection in sub-Saharan Africa

Suchergebnisse filtern